Yıl: 2023 Cilt: 4 Sayı: 1 Sayfa Aralığı: 35 - 36 Metin Dili: İngilizce DOI: 10.14744/hf.2022.2022.0018 İndeks Tarihi: 04-06-2023

Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis

Öz:
Hepatoportal sclerosis (HPS) is an idiopathic non-cirrhotic portal hyper - tension (INCPH) characterized by hypersplenism, portal hypertension, and splenomegaly. Hepatocellular carcinoma (HCC) is the most common form of liver cancer. Non-cirrhotic portal hypertension is an extremely rare cause of HCC. A 36-year-old woman was referred to our hospital with esophageal varices. All serologic tests for etiology were negative. Serum ceruloplasmin and serum Ig A-M-G were normal. In the follow-up, two liver lesions were identified on a triple-phase computer. The lesions had arterial enhancement but no washout in the venous phase. In the magnetic resonance imaging examination, differentiation in favor of HCC was considered at one of the lessions. Radiofrequency ablation therapy was first applied to a patient who had no signs of metastasis. Within 2 months, the patient underwent a living donor liver transplant. In explant pathology, well-differentiated HCC and HPS were considered the cause of non-cirrhotic portal hypertension. The patient has been followed without relapse for 3 years. The development of HCC in INCPH patients is still debatable. Despite the presence of liver cell atypia and pleomorphism in nodular regenerative hyperplasia liver speci- mens, a causal link between HCC and INCPH is yet to be established.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • 1. Schouten JN, Verheij J, Seijo S. Idiopathic non-cirrhotic portal hyperten- sion: A review. Orphanet J Rare Dis 2015;10:67. [CrossRef]
  • 2. Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2016;2:16018. [CrossRef]
  • 3. Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 2010;15(S4):14-22. [CrossRef]
  • 4. Gioia S, Nardelli S, Ridola L, Riggio O. Causes and management of non-cir- rhotic portal hypertension. Curr Gastroenterol Rep 2020;22(12):56.[CrossRef]
  • 5. Schouten JNL, Garcia-Pagan JC, Valla DC, Janssen HLA. Idiopathic non- cirrhotic portal hypertension. Hepatology 2011;54(3):1071-1081. [CrossRef]
APA Turan Gökçe D, Arı D, Gokcan H, Aydin O, Turhan N, Akdogan M (2023). Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis. , 35 - 36. 10.14744/hf.2022.2022.0018
Chicago Turan Gökçe Dilara,Arı Derya,Gokcan Hale,Aydin Osman,Turhan Nesrin,Akdogan Meral Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis. (2023): 35 - 36. 10.14744/hf.2022.2022.0018
MLA Turan Gökçe Dilara,Arı Derya,Gokcan Hale,Aydin Osman,Turhan Nesrin,Akdogan Meral Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis. , 2023, ss.35 - 36. 10.14744/hf.2022.2022.0018
AMA Turan Gökçe D,Arı D,Gokcan H,Aydin O,Turhan N,Akdogan M Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis. . 2023; 35 - 36. 10.14744/hf.2022.2022.0018
Vancouver Turan Gökçe D,Arı D,Gokcan H,Aydin O,Turhan N,Akdogan M Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis. . 2023; 35 - 36. 10.14744/hf.2022.2022.0018
IEEE Turan Gökçe D,Arı D,Gokcan H,Aydin O,Turhan N,Akdogan M "Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis." , ss.35 - 36, 2023. 10.14744/hf.2022.2022.0018
ISNAD Turan Gökçe, Dilara vd. "Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis". (2023), 35-36. https://doi.org/10.14744/hf.2022.2022.0018
APA Turan Gökçe D, Arı D, Gokcan H, Aydin O, Turhan N, Akdogan M (2023). Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis. Hepatology forum, 4(1), 35 - 36. 10.14744/hf.2022.2022.0018
Chicago Turan Gökçe Dilara,Arı Derya,Gokcan Hale,Aydin Osman,Turhan Nesrin,Akdogan Meral Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis. Hepatology forum 4, no.1 (2023): 35 - 36. 10.14744/hf.2022.2022.0018
MLA Turan Gökçe Dilara,Arı Derya,Gokcan Hale,Aydin Osman,Turhan Nesrin,Akdogan Meral Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis. Hepatology forum, vol.4, no.1, 2023, ss.35 - 36. 10.14744/hf.2022.2022.0018
AMA Turan Gökçe D,Arı D,Gokcan H,Aydin O,Turhan N,Akdogan M Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis. Hepatology forum. 2023; 4(1): 35 - 36. 10.14744/hf.2022.2022.0018
Vancouver Turan Gökçe D,Arı D,Gokcan H,Aydin O,Turhan N,Akdogan M Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis. Hepatology forum. 2023; 4(1): 35 - 36. 10.14744/hf.2022.2022.0018
IEEE Turan Gökçe D,Arı D,Gokcan H,Aydin O,Turhan N,Akdogan M "Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis." Hepatology forum, 4, ss.35 - 36, 2023. 10.14744/hf.2022.2022.0018
ISNAD Turan Gökçe, Dilara vd. "Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis". Hepatology forum 4/1 (2023), 35-36. https://doi.org/10.14744/hf.2022.2022.0018